Senior insider sale
Sr VP, Quality, GMP Oper. & IT at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$852.4K
19K shares
What this filing means
MOTTOLA FRANK plans to sell 19K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $852.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2025ACC: 0001950047-25-007031
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
19K
Shares to sell
$852.4K
Approx. market value
5K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
9/12/2025
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/12/2025 | Exercise of options under a registered plan Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
14K
Market value
$623.1K
8/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5K
Market value
$229.3K
9/12/2025
Total
Units
19K
Value
$852.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/25/2025 | 14K | $623.1K | — | Completed |
| Planned — Approximate Date | ||||
9/12/2025 | 5K | $229.3K | NASDAQ | Planned |
| Total | 19K | $852.4K | ||